These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19586653)

  • 21. Long-term complication due to dextranomer based implant: granuloma causing urinary obstruction.
    Bedir S; Kilciler M; Ozgök Y; Deveci G; Erduran D
    J Urol; 2004 Jul; 172(1):247-8. PubMed ID: 15201785
    [No Abstract]   [Full Text] [Related]  

  • 22. Editorial comment.
    Ginsberg DA
    Urology; 2009 Oct; 74(4):775; author reply 776-7. PubMed ID: 19800496
    [No Abstract]   [Full Text] [Related]  

  • 23. Editorial comment.
    Griebling TL
    Urology; 2009 Oct; 74(4):775-6; author reply 776-7. PubMed ID: 19800495
    [No Abstract]   [Full Text] [Related]  

  • 24. Transurethral injection therapy with dextranomer/hyaluronic acid copolymer (Deflux) for treatment of secondary vesicoureteral reflux after renal transplantation.
    Seifert HH; Mazzola B; Ruszat R; Muller A; Steiger J; Bachmann A; Sulser T
    J Endourol; 2007 Nov; 21(11):1357-60. PubMed ID: 18042030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postoperative ureteral obstruction after subureteral injection of dextranomer/hyaluronic Acid copolymer.
    Vandersteen DR; Routh JC; Kirsch AJ; Scherz HC; Ritchey ML; Shapiro E; Wolpert JJ; Pfefferle H; Reinberg Y
    J Urol; 2006 Oct; 176(4 Pt 1):1593-5. PubMed ID: 16952696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized controlled multisite trial of injected bulking agents for women with intrinsic sphincter deficiency: mid-urethral injection of Zuidex via the Implacer versus proximal urethral injection of Contigen cystoscopically.
    Lightner D; Rovner E; Corcos J; Payne C; Brubaker L; Drutz H; Steinhoff G;
    Urology; 2009 Oct; 74(4):771-5. PubMed ID: 19660800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stress urinary incontinence: feasibility of surgery after urethral injection.
    Fianu-Jonasson A; Edwall L
    Acta Obstet Gynecol Scand; 2003 Nov; 82(11):1060. PubMed ID: 14616284
    [No Abstract]   [Full Text] [Related]  

  • 28. An open, multicentre study of NASHA/Dx Gel (Zuidex) for the treatment of stress urinary incontinence.
    Chapple CR; Haab F; Cervigni M; Dannecker C; Fianu-Jonasson A; Sultan AH
    Eur Urol; 2005 Sep; 48(3):488-94. PubMed ID: 15967568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complications of Teflon injection for stress urinary incontinence.
    Kiilholma PJ; Chancellor MB; Makinen J; Hirsch IH; Klemi PJ
    Neurourol Urodyn; 1993; 12(2):131-7. PubMed ID: 7920669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histopathological changes associated with dextranomer/hyaluronic acid injection for pediatric vesicoureteral reflux.
    Routh JC; Ashley RA; Sebo TJ; Vandersteen DR; Slezak J; Reinberg Y
    J Urol; 2007 Oct; 178(4 Pt 2):1707-10. PubMed ID: 17707018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Foreign body granuloma caused by hyaluronic acid/dextranomer microsphere filler injection.
    Yang JH; Lee SM; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
    Int J Dermatol; 2012 Dec; 51(12):1517-8. PubMed ID: 23171022
    [No Abstract]   [Full Text] [Related]  

  • 32. Stress incontinence injection therapy: what is best for our patients?
    Chapple CR; Wein AJ; Brubaker L; Dmochowski R; Pons ME; Haab F; Hill S
    Eur Urol; 2005 Oct; 48(4):552-65. PubMed ID: 16118034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Recurrent periurethral pseudocysts after aspiration].
    Mouracade P
    Prog Urol; 2008 Dec; 18(13):1043-4. PubMed ID: 19041808
    [No Abstract]   [Full Text] [Related]  

  • 34. An Unusual Case of Submucosal Rectal Nodules.
    Tiernan J; Bhatt A; Liska D
    Gastroenterology; 2018 Oct; 155(4):e5-e6. PubMed ID: 29885317
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of stress urinary incontinence using a copolymer system: impact on quality of life.
    van Kerrebroeck P; ter Meulen F; Larsson G; Farrelly E; Edwall L; Fianu-Jonasson A
    BJU Int; 2004 Nov; 94(7):1040-3. PubMed ID: 15541124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obturator infected hematoma and urethral erosion following transobturator tape implantation.
    Game X; Mouzin M; Vaessen C; Malavaud B; Sarramon JP; Rischmann P
    J Urol; 2004 Apr; 171(4):1629. PubMed ID: 15017240
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of vesicoureteral reflux using endoscopic injection of nonanimal stabilized hyaluronic acid/dextranomer gel: initial experience in pediatric patients by a single surgeon.
    Yu RN; Roth DR
    Pediatrics; 2006 Aug; 118(2):698-703. PubMed ID: 16882825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for urinary tract infection after dextranomer/hyaluronic acid endoscopic injection.
    Traxel E; DeFoor W; Reddy P; Sheldon C; Minevich E
    J Urol; 2009 Oct; 182(4 Suppl):1708-12. PubMed ID: 19692024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel use of dextranomer/hyaluronic acid copolymer.
    Lambropoulos V; Mouravas V; Papageorgiou I; Spyridakis I; Marakis G
    Urologia; 2015; 82(1):71-3. PubMed ID: 24832471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Massive prolapse of the urethral mucosa following periurethral injection of calcium hydroxylapatite for stress urinary incontinence.
    Palma PC; Riccetto CL; Martins MH; Herrmann V; de Fraga R; Billis A; Netto NR
    Int Urogynecol J Pelvic Floor Dysfunct; 2006 Nov; 17(6):670-1. PubMed ID: 16341621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.